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Instant insight: think outside the cell 
Abstract 
Proteins perform many different functions critical for life, from building our muscle structure to digesting 
our food. These large biological molecules each have a unique three-dimensional shape which they 
require to perform their function. In protein deposition diseases (PDDs), however, a disease-specific 
protein molecule unfolds from its normal shape and assembles together with like molecules into 
insoluble rod-shaped fibrils. These protein deposits can be found in the brain, skeletal tissue and various 
organs; in some cases they may become large enough to disrupt tissue structure and function. 
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Instant Insight: Think outside the cell 
 
Proteins are large biological molecules which perform many different functions 
critical for life (e.g. making up the structure of muscle, digesting our food). They have 
a unique three-dimensional shape that is required for them to perform their function. 
In protein deposition diseases (PDDs) a disease-specific protein molecule unfolds 
from its normal shape and assembles together with many other unfolded molecules of 
the same protein to form insoluble rod-like fibrils. One of the most prevalent and 
costly PDDs is Alzheimer's disease (AD) but there are more than 40 diseases in this 
group including Parkinson's disease, mad cow disease and motor neurone disease. 
The protein deposits can be found in the brain, skeletal tissue and various organs; in 
some cases they may become large enough to disrupt tissue structure and function. 
When it is considered that cells and their surrounds (extracellular spaces) are densely 
packed with thousands of different proteins, and are exposed to many stresses capable 
of unfolding proteins, it seems miraculous that there are not more of these PDDs.  
 
Inside cells (i.e. intracellularly) there is a large amount of energy invested into 
ensuring that proteins reach and maintain their normal (native) shape. This quality 
control machinery includes molecular chaperones, which bind to hydrophobic (water-
hating) regions normally buried inside the native shape of a protein, and sophisticated 
degradation machinery such as the proteasome. There is little doubt that these 
intracellular mechanisms protect our bodies from PDDs which would otherwise 
produce harmful protein deposits inside cells. But what happens outside cells where 
many PDDs, including AD, produce insoluble deposits? The answer to this question 
is the focus of our review. Very little previous work has examined this question, being 
instead directed towards those now relatively well understood intracellular 
mechanisms. 
 
Recently, it was discovered that a small group of human blood proteins possess the 
ability to "chaperone" misfolded proteins (i.e. keep them soluble and inhibit their 
clumping together). Each of these “extracellular chaperones” (ECs; clusterin, 
haptoglobin and 2-macroglobulin) is bound by specific cell surface receptors that 
can internalise them and their ligands for subsequent degradation inside the cell. The 
ECs and their receptors may comprise the foundation of an extracellular system for 
quality control of protein folding. Such a system may be overwhelmed in extracellular 
PDDs such as AD. Consistent with the model proposed, it has been shown that in 
mouse brains the clearance of extracellular amyloid- peptide (which forms the 
plaques in the brain in AD) is much faster when it is bound to clusterin and slower 
when 2-macroglobulin or the 2-macroglobulin receptor are inhibited. Studies of the 
system(s) sensing and controlling protein folding in extracellular spaces of the body 
are in their infancy but in time are likely to produce important insights into the 
mechanisms underpinning extracellular PDDs. This will provide new opportunities to 
develop therapeutic strategies for a range of diseases that will have an increasing 
impact on an ageing world population. 
 
   
